148 related articles for article (PubMed ID: 162656)
21. Efficacy and safety of an ascending-dose, extended-regimen levonorgestrel/ethinyl estradiol combined oral contraceptive.
Portman DJ; Kaunitz AM; Howard B; Weiss H; Hsieh J; Ricciotti N
Contraception; 2014 Apr; 89(4):299-306. PubMed ID: 24576794
[TBL] [Abstract][Full Text] [Related]
22. Multicenter trial of a monophasic oral contraceptive containing ethinyl estradiol and desogestrel.
Rekers H
Acta Obstet Gynecol Scand; 1988; 67(2):171-4. PubMed ID: 2972160
[TBL] [Abstract][Full Text] [Related]
23. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
[TBL] [Abstract][Full Text] [Related]
24. Safety and bleeding profile of continuous levonorgestrel 90 mcg/ethinyl estradiol 20 mcg based on 2 years of clinical trial data in Canada.
Reid RL; Fortier MP; Smith L; Mirkin S; Grubb GS; Constantine GD
Contraception; 2010 Dec; 82(6):497-502. PubMed ID: 21074011
[TBL] [Abstract][Full Text] [Related]
25. Open prospective multicenter trial with a new monophasic contraceptive combination containing gestodene.
Renier M; Buytaert P
Contraception; 1991 May; 43(5):413-21. PubMed ID: 1914456
[TBL] [Abstract][Full Text] [Related]
26. Plasma concentrations of vasopressin and a prostaglandin F2 alpha metabolite in women with primary dysmenorrhoea before and during treatment with a combined oral contraceptive.
Hauksson A; Akerlund M; Forsling ML; Kindahl H
J Endocrinol; 1987 Nov; 115(2):355-61. PubMed ID: 3125302
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of a new triphasic oral contraceptive in private practice.
Ellsworth HS; Ayerst RI; Harris JW; Stone RA; Anderson AE; Jones TL; Curtis MK
Contraception; 1986 Nov; 34(5):435-42. PubMed ID: 3102161
[TBL] [Abstract][Full Text] [Related]
28. Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy.
Rosenfeld WE; Doose DR; Walker SA; Nayak RK
Epilepsia; 1997 Mar; 38(3):317-23. PubMed ID: 9070594
[TBL] [Abstract][Full Text] [Related]
29. An investigation into the effect of tenidap sodium on the pharmacokinetics of a combined oral contraceptive.
Coates PE; Mesure R
Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):47S-50S. PubMed ID: 7547095
[TBL] [Abstract][Full Text] [Related]
30. Serum lipid and lipoprotein changes induced by new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel.
Gaspard UJ; Buret J; Gillain D; Romus MA; Lambotte R
Contraception; 1985 Apr; 31(4):395-408. PubMed ID: 3159546
[TBL] [Abstract][Full Text] [Related]
31. Low-dose ethinylestradiol/levonorgestrel.
Dando TM; Curran MP
Drugs; 2005; 65(16):2299-306; discusion 2307-8. PubMed ID: 16266199
[TBL] [Abstract][Full Text] [Related]
32. Comparative study on the efficacy and acceptability of two contraceptive pills administered by the vaginal route: an international multicenter clinical trial.
Coutinho EM; de Souza JC; da Silva AR; de Acosta OM; Alvarez F; Brache V; Garza Flores J; Vasquez-Estrada L; Santo R; Bassol S
Clin Pharmacol Ther; 1993 Jan; 53(1):65-75. PubMed ID: 8422744
[TBL] [Abstract][Full Text] [Related]
33. Effects of three low-dose oral contraceptive formulations on lipid metabolism.
Bertolini S; Elicio N; Cordera R; Gapitanio GL; Montagna G; Croce S; Saturnino M; Balestreri R; De Cecco L
Acta Obstet Gynecol Scand; 1987; 66(4):327-32. PubMed ID: 2962417
[TBL] [Abstract][Full Text] [Related]
34. Randomized comparison of bleeding patterns in women using a combined contraceptive vaginal ring or a low-dose combined oral contraceptive on a menstrually signaled regimen.
Weisberg E; Merki-Feld GS; McGeechan K; Fraser IS
Contraception; 2015 Feb; 91(2):121-6. PubMed ID: 25459098
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of levonorgestrel in 18 women after 1 month of treatment with a triphasic oral contraceptive.
Kuhnz W; al-Yacoub G
Horm Res; 1991; 35(5):178-81. PubMed ID: 1802819
[TBL] [Abstract][Full Text] [Related]
36. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.
Wilson ES; Cruickshank J; McMaster M; Weir RJ
Br J Obstet Gynaecol; 1984 Dec; 91(12):1254-60. PubMed ID: 6440589
[TBL] [Abstract][Full Text] [Related]
37. The relative bioavailability of levonorgestrel and ethinyl estradiol administered as a low-dose combination oral contraceptive.
Goebelsmann U; Hoffman D; Chiang S; Woutersz T
Contraception; 1986 Oct; 34(4):341-51. PubMed ID: 3096634
[TBL] [Abstract][Full Text] [Related]
38. Effect of low-dose oral contraceptives on androgenic markers and acne.
Thorneycroft IH; Stanczyk FZ; Bradshaw KD; Ballagh SA; Nichols M; Weber ME
Contraception; 1999 Nov; 60(5):255-62. PubMed ID: 10717776
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of levonorgestrel and ethinylestradiol in 9 women who received a low-dose oral contraceptive over a treatment period of 3 months and, after a wash-out phase, a single oral administration of the same contraceptive formulation.
Kuhnz W; al-Yacoub G; Fuhrmeister A
Contraception; 1992 Nov; 46(5):455-69. PubMed ID: 1458892
[TBL] [Abstract][Full Text] [Related]
40. Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel.
Ahrendt HJ; Makalová D; Parke S; Mellinger U; Mansour D
Contraception; 2009 Nov; 80(5):436-44. PubMed ID: 19835717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
